Cargando…
COVID-19 Vaccination: Does It Alter Postoperative Mortality and Morbidity in Hip Fractures?
Introduction The primary aim of our study was to evaluate the impact of coronavirus disease 2019 (COVID-19) vaccination on mortality in patients with hip fractures by comparing it to those who are unvaccinated. Our secondary objective was to compare the impact on postoperative morbidity parameters l...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762274/ https://www.ncbi.nlm.nih.gov/pubmed/36545356 http://dx.doi.org/10.7759/cureus.32688 |
_version_ | 1784852829673881600 |
---|---|
author | Jagadeesh, Nuthan Gnany, Jabez Kapadi, Sachindra Koshy, Nidhin Shaw, Debbie |
author_facet | Jagadeesh, Nuthan Gnany, Jabez Kapadi, Sachindra Koshy, Nidhin Shaw, Debbie |
author_sort | Jagadeesh, Nuthan |
collection | PubMed |
description | Introduction The primary aim of our study was to evaluate the impact of coronavirus disease 2019 (COVID-19) vaccination on mortality in patients with hip fractures by comparing it to those who are unvaccinated. Our secondary objective was to compare the impact on postoperative morbidity parameters like length of hospital stay and complications. Methods A total of 619 hip fractures were divided into the 'Vaccinated group' consisting of 300 patients who had COVID-19 vaccination and the 'Unvaccinated group' consisting of 319 patients who were not vaccinated. Patient demographic variables, Nottingham hip fracture score, American Society of Anesthesiologists (ASA) grade, type of anaesthesia used, and Charlson Comorbidity Index were collected. Our primary outcome measures were 30- and 90-day mortality. Secondary outcome measures included postoperative complications like thromboembolic complications, cardiac, and respiratory complications, etc. Mortality among the COVID-positive patients was also compared between the groups. Results Thirty-day postoperative mortality was higher in the unvaccinated group at 13.2% than in the vaccinated group at 5.3%. A similar increase in 90-day mortality was also observed in the unvaccinated group at 24.8% when compared to 14.7% in the vaccinated group(p<0.001). Despite having a higher baseline prevalence of cardiac comorbidities, the Vaccinated group had fewer post-operative cardiac, thromboembolic, and neurological complications (p>0.05). Moreover, electrolyte imbalance and AKI were also seen in fewer patients in the vaccinated group compared to the control group (p<0.05). Furthermore, it was found that among the vaccinated patients who did have perioperative COVID-19 infection, the 30-day mortality was significantly lower (10%) compared to the control group (31.2%) (p<0.001). Similarly, 90-day mortality was significantly lower (25%) compared to the control group (43.75%) (p<0.001). Conclusion Vaccination against COVID-19 independently reduced mortality and morbidity among patients with hip fractures when compared to those who are not vaccinated. Furthermore, it decreased the risk of acquiring COVID-19, and subsequent postoperative complications. Among those who are infected with COVID-19 despite vaccination, the mortality was significantly lesser. |
format | Online Article Text |
id | pubmed-9762274 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-97622742022-12-20 COVID-19 Vaccination: Does It Alter Postoperative Mortality and Morbidity in Hip Fractures? Jagadeesh, Nuthan Gnany, Jabez Kapadi, Sachindra Koshy, Nidhin Shaw, Debbie Cureus Other Introduction The primary aim of our study was to evaluate the impact of coronavirus disease 2019 (COVID-19) vaccination on mortality in patients with hip fractures by comparing it to those who are unvaccinated. Our secondary objective was to compare the impact on postoperative morbidity parameters like length of hospital stay and complications. Methods A total of 619 hip fractures were divided into the 'Vaccinated group' consisting of 300 patients who had COVID-19 vaccination and the 'Unvaccinated group' consisting of 319 patients who were not vaccinated. Patient demographic variables, Nottingham hip fracture score, American Society of Anesthesiologists (ASA) grade, type of anaesthesia used, and Charlson Comorbidity Index were collected. Our primary outcome measures were 30- and 90-day mortality. Secondary outcome measures included postoperative complications like thromboembolic complications, cardiac, and respiratory complications, etc. Mortality among the COVID-positive patients was also compared between the groups. Results Thirty-day postoperative mortality was higher in the unvaccinated group at 13.2% than in the vaccinated group at 5.3%. A similar increase in 90-day mortality was also observed in the unvaccinated group at 24.8% when compared to 14.7% in the vaccinated group(p<0.001). Despite having a higher baseline prevalence of cardiac comorbidities, the Vaccinated group had fewer post-operative cardiac, thromboembolic, and neurological complications (p>0.05). Moreover, electrolyte imbalance and AKI were also seen in fewer patients in the vaccinated group compared to the control group (p<0.05). Furthermore, it was found that among the vaccinated patients who did have perioperative COVID-19 infection, the 30-day mortality was significantly lower (10%) compared to the control group (31.2%) (p<0.001). Similarly, 90-day mortality was significantly lower (25%) compared to the control group (43.75%) (p<0.001). Conclusion Vaccination against COVID-19 independently reduced mortality and morbidity among patients with hip fractures when compared to those who are not vaccinated. Furthermore, it decreased the risk of acquiring COVID-19, and subsequent postoperative complications. Among those who are infected with COVID-19 despite vaccination, the mortality was significantly lesser. Cureus 2022-12-19 /pmc/articles/PMC9762274/ /pubmed/36545356 http://dx.doi.org/10.7759/cureus.32688 Text en Copyright © 2022, Jagadeesh et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Other Jagadeesh, Nuthan Gnany, Jabez Kapadi, Sachindra Koshy, Nidhin Shaw, Debbie COVID-19 Vaccination: Does It Alter Postoperative Mortality and Morbidity in Hip Fractures? |
title | COVID-19 Vaccination: Does It Alter Postoperative Mortality and Morbidity in Hip Fractures? |
title_full | COVID-19 Vaccination: Does It Alter Postoperative Mortality and Morbidity in Hip Fractures? |
title_fullStr | COVID-19 Vaccination: Does It Alter Postoperative Mortality and Morbidity in Hip Fractures? |
title_full_unstemmed | COVID-19 Vaccination: Does It Alter Postoperative Mortality and Morbidity in Hip Fractures? |
title_short | COVID-19 Vaccination: Does It Alter Postoperative Mortality and Morbidity in Hip Fractures? |
title_sort | covid-19 vaccination: does it alter postoperative mortality and morbidity in hip fractures? |
topic | Other |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762274/ https://www.ncbi.nlm.nih.gov/pubmed/36545356 http://dx.doi.org/10.7759/cureus.32688 |
work_keys_str_mv | AT jagadeeshnuthan covid19vaccinationdoesitalterpostoperativemortalityandmorbidityinhipfractures AT gnanyjabez covid19vaccinationdoesitalterpostoperativemortalityandmorbidityinhipfractures AT kapadisachindra covid19vaccinationdoesitalterpostoperativemortalityandmorbidityinhipfractures AT koshynidhin covid19vaccinationdoesitalterpostoperativemortalityandmorbidityinhipfractures AT shawdebbie covid19vaccinationdoesitalterpostoperativemortalityandmorbidityinhipfractures |